skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

5 studies were found about ( ibalizumab OR TMB-355 OR TNX-355 OR Hu5A8 )

Compassionate Use of Dolutegravir and Ibalizumab for the Treatment of HIV Infection

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT02028819

TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

Condition: HIV Infections

NCT ID: NCT00089700

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Condition: HIV

NCT ID: NCT00784147

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

Condition: HIV Infections

NCT ID: NCT01056393

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

Condition: Prevention of Infection With HIV-1

NCT ID: NCT01292174